A Cost-effective Satellite-aircraft-drogue Approach for Studying Estuarine Circulation and Shelf Waste Dispersion

The author has identified the following significant results. Satellites, such as ERTS-1, can be used to obtain a synoptic view of current circulation over large coastal areas. Since in turbid coastal regions suspended sediment acts as a natural tracer, cost is minimized by eliminating the need for expensive injections of large volumes of dye such as Rhodamine-B. One of the principal shortcomings of satellite imaging of coastal currents was its inability to determine current magnitude and to penetrate beyond the upper few meters of the water column. These objections were overcome by complementing satellite observations with drogues tracking currents at various selected depths. By combining the satellite's wide coverage with aircraft or shore stations capable of tracking expendable drogues, a cost effective, integrated system was devised for monitoring currents over large areas, various depths, and under severe environmental conditions

Develop and test fuel cell powered on-site integrated total energy system

Test results are presented for a 24 cell, two sq ft (4kW) stack. This stack is a precursor to a 25kW stack that is a key milestone. Results are discussed in terms of cell performance, electrolyte management, thermal management, and reactant gas manifolding. The results obtained in preliminary testing of a 50kW methanol processing subsystem are discussed. Subcontracting activities involving application analysis for fuel cell on site integrated energy systems are updated

Medical applications of space light-emitting diode technology-space station and beyond

Journal ArticleSpace light-emitting diode (LED) technology has provided medicine with a new tool capable of delivering light deep into tissues of the body, at wavelengths which are biologically optimal for cancer treatment and wound healing. This LED technology has already flown on Space Shuttle missions, and shows promise for wound healing applications of benefit to Space Station astronauts

Benzoporphyrin derivative and light-emitting diode for use in photodynamic therapy: applications of space light-emitting diode technology

Journal ArticlePhotodynamic therapy (PDT) is a cancer treatment modality that recently has been applied as adjuvant therapy for rain tumors. PDT consists of intravenously injecting a photosensitizer, which preferentially accumulates in tumor ells, into a patient and then activating the photosensitizer with a light source. This results in free radical generation ollowed by cell death. The development of more effective light sources for PDT of brain tumors has been facilitated by applications of space light-emitting diode array technology; thus permitting deeper tumor penetration of light and use of better photosensitizers. Currently, the most commonly used photosensitizer for brain tumor PDT is Photofrin®. Photofrin® is a heterogeneous mixture of compounds derived from hematoporphyrin. Photofrin® is ctivated with a 630 nm laser light and does destroy tumor cells in animal models and humans. However, treatment "ailure does occur using this method. Most investigators attribute this failure to the limited penetration of brain tissue by a 630 nm laser light and to the fact that Photofrin® has only a minor absorption peak at 630 nm, meaning that only a small fraction of the chemical is activated. Benzoporphyrin Derivative Monoacid Ring A (BPD) is a new, second generation photosensitizer that can potentially improve PDT for brain tumors. BPD has a major absorption peak at 690 nm, which gives it two distinct advantages over Photofrin®. First, longer wavelengths of light penetrate brain tissue more easily so that larger tumors could be treated, and second, the major absorption peak means that a larger fraction of the drug is activated upon exposure to light. In the first part of this project we have tudied the tumoricidal effects of BPD in vitro using 2A9 canine glioma and U373 human glioblastoma cell cultures. Using light emitting diodes (LED) with a peak emission of 688 nm as a light source, cell kill of up to 86 percent was measured in these cell lines by tumor DNA synthesis reduction. The effectiveness of BPD against tumor cells in vitro thus established, we have taken the first step toward determining its effectiveness in vivo. The second part of this project consisted of experiments performed to determine the maximum tolerated dose (MTD) of both BPD and LED light. At a light dose of 100 J/cm^2, skin damage and neurotoxicity were seen at a BPD dose of 1.0 mg/kg, but not at a dose of 0.75 mg/kg. When BPD remained constant at 0.75 mg/kg, skin damage was seen at light dosages of 125 J/cm^2, 150 J/cm^2 and 175 J/cm^2. One dog also died at a light dose of 175 J/cm^2. Further studies will be needed to determine the effectiveness of BPD against tumor cells in vivo